Vaccinogen Completes Initial Closing of an $80 Million Financing
PR Newswire - Mon Aug 25, 6:00AM CDT
Vaccinogen, Inc., (OTC.QB: VGEN) a cancer immunotherapy development company, announced today that it completed the initial closing of a private placement of $80 million of units and common stock. Vaccinogen received gross proceeds of $10 million in this first closing.